Joshua A Kazam is a director of Kronos Bio Inc.
Person profile
Roles
Kronos Bio
Director
Allogene Therapeutics
Director
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kronos Bio, Inc.
26 Jun 23
4
Allogene Therapeutics, Inc.
15 Jun 23
4
Kronos Bio, Inc.
29 Jun 22
4
Allogene Therapeutics, Inc.
17 Jun 22
4
Allogene Therapeutics, Inc.
9 Mar 22
4
Kronos Bio, Inc.
9 Mar 22
4
Allogene Therapeutics, Inc.
14 Jan 22
3
Screaming Eagle Acquisition Corp.
6 Jan 22
4
Kronos Bio, Inc.
23 Jun 21
4
Allogene Therapeutics, Inc.
11 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jun 23 | KRON Kronos Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 1.48 | 34,000 | 50.32 k | 34,000 |
13 Jun 23 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.7 | 116,120 | 661.88 k | 116,120 |